查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093378

膜氧合市場－2026-2032年全球市場預測

Membrane Oxygenators Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，膜氧合（MEP）市場將成長至 2.4961 億美元，複合年成長率為 6.31%。

主要市場統計數據
基準年 2025 1.6258億美元
預計年份：2026年 1.7235億美元
預測年份 2032 2.4961億美元
複合年成長率 (%) 6.31%

膜式氧合器（MEP）是體外生命維持系統的重要組成部分，它透過在心肺體外迴圈、體外膜氧合（ECMO）及相關緊急醫療程序中提供氧氣和清除二氧化碳來實現血液氣體交換。隨著複雜心血管手術、嚴重呼吸衰竭、急性呼吸窘迫症候群（ARDS）、移植過渡治療以及臨時循環和肺部支持的發展，膜式氧合器在醫院的臨床意義日益凸顯。現代膜式氧合器通常採用中空纖維膜技術，旨在提高生物相容性、提供可控的氣體交換支援、減少血液損傷，並可與幫浦、熱交換器、感測器和肝素塗層迴路整合。

膜式氧合器 (MEV) 的市場趨勢受到以下因素的影響：對先進心肺護理的需求不斷成長、體外膜氧合 (ECMO) 項目的擴展、灌注治療實踐的改進以及重症監護技術的廣泛應用。諸如「體外膜氧合 (ECMO)」、「中空纖維氧合器」、「心肺體外迴圈氧合器」、「兒童氧合器」、「成人氧合器」、「聚甲基戊烯膜」、「重症監護灌注」和「血氣交換」等行業關鍵字仍然是採購、臨床評估和產品開發的核心。隨著醫療設備的選擇越來越注重實證醫學，決策者優先考慮安全性、可靠性、易於預充、發炎反應低、血液相容性以及與醫療規範的兼容性。

膜氧合領域的變革性變化。

膜式氧合（MEL）領域正從專用於特定手術的灌注裝置轉向可滿足多種應用場景（包括手術室、加護病房、急診室和轉運）的整合式體外生命維持平台。一個顯著的變化是，在正規培訓計畫、多學科ECMO團隊的支持下，ECMO在臨床上的應用範圍已擴展到高度專業化的醫療機構之外，並更加注重循證醫學的患者選擇、抗凝血治療、迴路監測和撤機方案。

人工智慧對膜式氧合器的累積影響

儘管臨床應用仍依賴檢驗、互通性和監管，但隨著體外生命支持的廣泛數位化，人工智慧正開始對膜式氧合器（MCL）產生影響。人工智慧驅動的分析功能支援對迴路壓力、血流量、氧飽和度、掃氣參數、抗凝血指標、溶血訊號和病患生命徵象進行持續分析。將這些工具整合到醫院監護系統中，有助於臨床醫生識別與氧合器血栓、氣體交換能力下降、循環或迴路不穩定相關的早期預警模式。

關於膜式氧合器的關鍵區域見解

在亞太地區，隨著人口密集的醫療體系中三級醫療機構不斷擴大心臟外科手術、呼吸重症監護和體外膜氧合（ECMO）能力，ECMO 的應用正在加速。中國、日本、韓國、印度、澳洲和東南亞主要國家正透過專科培訓、投資醫院基礎設施和重症監護現代化來加強體外生命維持計畫。日本和韓國充分利用其先進的心臟醫療網路和成熟的臨床工程能力，而印度和東南亞國家則日益重視體外循環支持的可及性、可負擔性和擴充性。

膜式氧合器的主要群體分析

北約成員國與北美和歐洲的先進醫療網路高度重合，這些國家的緊急準備、軍事醫療服務、體外膜氧合（ECMO）轉運以及穩健的供應鏈都會影響體外生命支持技術的採購優先事項。七國集團（G7）國家通常擁有成熟的體外循環系統、先進的重症監護能力、健全的臨床管治和嚴格的品質標準，這些因素推動了對技術先進、安全可靠且經過充分驗證的膜式氧合系統的需求，這些系統可用於心臟手術、器官移植和重症監護。

主要國家膜式氧合器（MEB）的發展趨勢

在中國，隨著醫院現代化、重症監護投入以及主要醫療中心體外膜氧合（ECMO）能力的提升，膜式氧合器（MEA）的應用正在不斷擴展。美國是MEA領域最先進的國家之一，其應用已廣泛應用於心臟外科手術、ECMO計畫、器官移植中心、轉運醫學和兒童重症監護，並擁有專業的灌注和重症監護團隊的支援。日本擁有成熟的醫療環境，具備先進的心肺支援技術、高度重視醫療品質以及完善的臨床規範。在印度，由於心血管疾病負擔日益加重、私人醫院網路不斷擴張以及人們對ECMO培訓的興趣日益濃厚，對MEA的需求也在不斷成長，但價格和熟練人員的短缺仍然是重要的考慮因素。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的創新技術，這些技術能夠提高成人、兒童和新生兒應用中的血液相容性、氣體交換效率、易用性和安全性。產品開發應著重於低預充設計、最佳化的中空纖維形狀、耐用的聚甲基戊烯膜、改進的表面塗層、整合的熱交換功能以及與數位監測系統的兼容性。由於膜式氧合器用於高風險情況，因此易用性、整合警報功能和清晰的設定流程必須是設計策略的核心。

調查方法

本執行摘要採用系統性的二手調查方法撰寫，重點在於檢驗的臨床、監管和產業相關資訊來源。該方法強調來自同行評審的醫學文獻、臨床實踐指南、監管文件、醫療設備安全和品質標準、醫院技術應用趨勢以及公開的醫療基礎設施資訊的證據。關鍵主題的評估涵蓋器材技術、臨床應用、區域應用促進因素、重症監護能力、灌注實務和數位轉型等面向。

結論

膜式氧合器（ECMO）在現代心臟外科手術和體外生命支持中仍然至關重要，隨著醫院不斷提升其先進的呼吸和循環支持能力，其重要性日益凸顯。中空纖維膜材料、生物相容性塗層、迴路整合、臨床訓練、供應穩定性以及實證ECMO方案的進步，正在改變這一領域的格局。儘管各地情況差異顯著，但安全性、可靠性、臨床醫生的準備情況以及獲得高品質體外生命支持服務是通用的優先事項。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 膜氧合市場：依類型分類

  • 中空纖維膜氧合器
  • 平板膜式氧合器
  • 螺旋纏繞式膜氧合器

第8章 膜式氧合器市場：依材料分類

  • 聚甲基戊烯
  • 聚丙烯
  • 聚碸
  • 複合聚合物

第9章 膜式氧合器市場：依用途分類

  • 拋棄式氧合裝置
  • 可重複使用的氧合設備

第10章 膜式氧合器市場：依技術分類

  • 微孔膜技術
  • 固體矽薄膜技術
  • 聚丙烯薄膜技術
  • 聚甲基戊烯薄膜技術

第11章 膜式氧合市場：依病患年齡層別分類

  • 新生
  • 兒童
  • 成人

第12章 膜式氧合器市場：依流量類型分類

  • 連續型
  • 脈衝型

第13章 膜式氧合器市場：依應用領域分類

  • 血液氧合研究
    • 動物實驗
    • 體外試驗
  • 心肺體外迴圈
    • 冠狀動脈繞道手術手術
    • 瓣膜置換術
  • 體外膜氧合（ECMO）
    • 靜脈-動脈體外膜氧合（ECMO）
    • 靜脈-靜脈體外膜氧合（ECMO）

第14章 膜式氧合器市場：依最終用戶分類

  • 門診手術中心
  • 醫院和研究機構
  • 專業心臟病中心
  • 急診中心

第15章 膜式氧合器市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第16章 膜式氧合器市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第17章 膜式氧合器市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第18章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Abbott Laboratories
  • Andocor NV
  • B. Braun Melsungen AG
  • Braile Biomedica
  • Chalice Medical Ltd.
  • Cytosorbents Corporation
  • Dongguan Kewei Medical Instrument Co., Ltd.
  • Eurosets Srl
  • Fresenius SE & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • Jafron Biomedical
  • LivaNova PLC
  • Medos Medizintechnik AG
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Spectrum Medical Ltd.
  • Terumo Corporation
  • Xenios AG
Product Code: MRR-3E7F10ED1B0D

The Membrane Oxygenators Market is projected to grow by USD 249.61 million at a CAGR of 6.31% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 162.58 million
Estimated Year [2026] USD 172.35 million
Forecast Year [2032] USD 249.61 million
CAGR (%) 6.31%

Membrane oxygenators are critical components of extracorporeal life support systems, enabling blood gas exchange by adding oxygen and removing carbon dioxide during cardiopulmonary bypass, extracorporeal membrane oxygenation, and related critical care interventions. Their clinical relevance has expanded as hospitals manage complex cardiac surgery, severe respiratory failure, acute respiratory distress syndrome, bridge-to-transplant cases, and temporary circulatory or pulmonary support. Modern devices typically use hollow-fiber membrane technology designed to improve biocompatibility, support controlled gas transfer, reduce blood trauma, and integrate with pumps, heat exchangers, sensors, and heparin-coated circuits.

The membrane oxygenators landscape is shaped by rising demand for advanced cardiac and pulmonary care, growing adoption of ECMO programs, improvements in perfusion practices, and broader use of intensive care technologies. Industry keywords such as extracorporeal membrane oxygenation, hollow-fiber oxygenator, cardiopulmonary bypass oxygenator, pediatric oxygenator, adult oxygenator, polymethylpentene membrane, critical care perfusion, and blood gas exchange remain central to procurement, clinical evaluation, and product development. Decision-makers are prioritizing safety, reliability, ease of priming, reduced inflammatory response, hemocompatibility, and compatibility with institutional protocols as device selection becomes increasingly evidence-driven.

Transformative Shifts in the Membrane Oxygenators Landscape

The membrane oxygenators sector is moving from procedure-specific perfusion equipment toward integrated extracorporeal support platforms that support operating room, intensive care, emergency, and transport use cases. A major shift is the increased clinical normalization of ECMO beyond highly specialized centers, supported by formalized training pathways, multidisciplinary ECMO teams, and greater alignment with evidence-based protocols for patient selection, anticoagulation, circuit surveillance, and weaning.

Technology evolution is also reshaping the landscape. Polymethylpentene hollow-fiber membranes have gained clinical importance because they support longer-duration gas exchange compared with older microporous polypropylene designs, particularly in ECMO applications. Improvements in surface coatings, blood-flow dynamics, heat-exchange efficiency, miniaturized circuit architecture, and integrated monitoring are aimed at reducing hemolysis, thrombosis, plasma leakage, inflammatory activation, and priming volume. Pediatric and neonatal care continues to drive specialized design requirements, including low resistance, low prime volume, and precise flow control.

Operationally, hospitals are placing greater emphasis on supply resilience, standardized disposables, clinician training, and rapid deployment readiness. The experience of respiratory pandemics, severe influenza seasons, and mass critical care surges highlighted the importance of durable procurement systems, device interchangeability, and cross-trained perfusion and intensive care personnel. Regulatory scrutiny and post-market surveillance are reinforcing expectations around device traceability, material safety, sterilization validation, and clinical performance documentation.

Cumulative Impact of Artificial Intelligence on Membrane Oxygenators

Artificial intelligence is beginning to influence membrane oxygenators through the broader digitization of extracorporeal life support, even though clinical adoption remains dependent on validation, interoperability, and regulatory oversight. AI-enabled analytics can support continuous interpretation of circuit pressures, blood flow, oxygen saturation, sweep gas parameters, anticoagulation indicators, hemolysis signals, and patient vital signs. When integrated into hospital monitoring systems, these tools can help clinicians identify early warning patterns associated with oxygenator clotting, gas transfer decline, recirculation, or circuit instability.

In manufacturing and quality systems, artificial intelligence and machine learning support process optimization, defect detection, material consistency analysis, and predictive quality control for hollow-fiber bundles, housing integrity, sterilization assurance, and packaging inspection. These applications are relevant because membrane oxygenators require precise performance consistency under high-risk clinical conditions.

AI is also strengthening research and clinical workflow. Data-driven models can assist with patient stratification, ECMO candidacy assessment, anticoagulation protocol refinement, resource planning, and simulation-based training. However, the responsible use of AI in extracorporeal support requires explainable algorithms, validated datasets, cybersecurity safeguards, human-in-the-loop clinical governance, and alignment with medical device regulations. The cumulative impact is not the replacement of perfusionists or intensivists, but the creation of smarter decision-support environments that improve vigilance, standardization, and operational readiness.

Key Regional Insights for Membrane Oxygenators

Asia-Pacific is experiencing deeper adoption of membrane oxygenators as tertiary hospitals expand cardiac surgery, respiratory intensive care, and ECMO capabilities across high-population healthcare systems. China, Japan, South Korea, India, Australia, and major Southeast Asian countries are strengthening extracorporeal life support programs through specialist training, hospital infrastructure investment, and critical care modernization. Japan and South Korea benefit from advanced cardiac care networks and mature clinical engineering capabilities, while India and Southeast Asia show rising emphasis on access, affordability, and scalable perfusion support.

Europe demonstrates strong adoption through well-established cardiac surgery programs, national healthcare systems, cross-border clinical collaboration, and strict device safety frameworks. Germany, France, Italy, Spain, and the United Kingdom maintain robust perfusion and intensive care practices, while Eastern European systems continue modernizing access and procurement pathways. The region's medical device environment emphasizes clinical evidence, post-market surveillance, material safety, and traceability, making compliance and quality documentation central to membrane oxygenator procurement.

North America remains characterized by advanced ECMO utilization, established perfusion education, sophisticated intensive care infrastructure, and strong regulatory expectations for safety and quality. The United States and Canada have extensive cardiac surgery, transplant, and pediatric critical care ecosystems, with hospitals focusing on integrated circuits, standardized protocols, and training to support adult, pediatric, and neonatal patients. Demand is linked to complex cardiopulmonary procedures, advanced heart and lung failure care, transport ECMO, and emergency preparedness.

Latin America is advancing unevenly, with Brazil and Mexico serving as important centers for cardiac surgery, extracorporeal support training, and tertiary care development. Access is influenced by public and private healthcare funding, import dependence, regional distribution capacity, and the availability of trained perfusionists and critical care teams. The Middle East is strengthening extracorporeal support capabilities through investment in tertiary hospitals, cardiac centers, transplant services, and critical care specialization, particularly in high-income Gulf health systems. Africa presents a more heterogeneous landscape, with membrane oxygenator adoption concentrated in leading urban and academic hospitals; broader availability is shaped by infrastructure, affordability, trained personnel, reliable supply chains, and access to cardiac and intensive care services.

Key Group Insights for Membrane Oxygenators

NATO countries overlap significantly with North American and European advanced care networks, where emergency preparedness, military medicine, transport ECMO, and resilient supply chains can influence procurement priorities for extracorporeal support technologies. G7 countries generally have mature perfusion ecosystems, advanced intensive care capacity, strong clinical governance, and rigorous quality expectations, driving demand for technologically advanced, safe, and well-documented membrane oxygenator systems used across cardiac surgery, transplant, and critical care settings.

BRICS countries represent diverse but strategically important demand environments. China and India are expanding access through large-scale hospital modernization, critical care investment, and domestic medical technology capabilities; Brazil anchors adoption in Latin America; Russia maintains established cardiac surgery centers; and South Africa serves as a regional hub for advanced procedures in parts of Africa. The European Union provides a highly regulated environment for membrane oxygenators, with medical device compliance, clinical evidence, post-market surveillance, and procurement transparency shaping purchasing decisions. Harmonized regulatory oversight and strong cardiac surgery networks support consistent quality expectations across member states.

ASEAN countries are increasingly relevant for membrane oxygenators as healthcare systems expand cardiac surgery, emergency care, and intensive care capacity. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines show varying levels of ECMO readiness, with regional differences driven by hospital investment, specialist training, reimbursement structures, and access to imported consumables. The group's priorities include affordability, clinician education, reliable distribution, and scalable critical care device access. GCC health systems are investing in advanced cardiac, transplant, and critical care services, creating a favorable environment for high-acuity extracorporeal technologies supported by tertiary hospital expansion, international clinical partnerships, and emphasis on specialized care delivery.

Key Country Insights for Membrane Oxygenators

China is expanding membrane oxygenator use through hospital modernization, critical care investment, and increased ECMO capability in leading medical centers. The United States is one of the most advanced environments for membrane oxygenators due to broad use in cardiac surgery, ECMO programs, transplant centers, transport medicine, and pediatric critical care, supported by specialized perfusion and intensive care teams. Japan has a mature environment with advanced cardiac and respiratory support practices, a strong focus on quality, and established clinical protocols. India shows growing demand linked to cardiovascular disease burden, expanding private hospital networks, and rising interest in ECMO training, while affordability and skilled workforce availability remain important considerations.

Germany has a prominent role due to its extensive hospital infrastructure, cardiovascular surgery expertise, and clinical engineering strength. The United Kingdom maintains advanced ECMO and cardiac surgery services supported by specialized centers and national clinical governance. Australia benefits from high-standard tertiary care networks, retrieval and transport medicine capabilities, and specialized ECMO services. France demonstrates mature adoption across intensive care and surgical settings, supported by structured healthcare delivery and advanced hospital networks. South Korea continues to demonstrate advanced adoption through technologically sophisticated hospitals, strong cardiovascular programs, and critical care modernization.

Italy and Spain continue to rely on membrane oxygenators across cardiac surgery and critical care, with expertise concentrated in major hospitals and academic centers. Canada shows strong adoption through tertiary hospitals and publicly funded healthcare systems, with emphasis on evidence-based protocols and regionalized access to advanced cardiopulmonary support. Russia has established cardiac centers and perfusion capabilities, though procurement and access can be affected by regional and policy factors. Brazil is a leading Latin American adopter, supported by a large hospital base, established cardiovascular care centers, and growing ECMO expertise. Mexico continues to strengthen cardiac care capacity, particularly in major urban centers, while access varies across public and private systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves hemocompatibility, gas transfer efficiency, usability, and safety across adult, pediatric, and neonatal applications. Product development should focus on low-prime designs, optimized hollow-fiber geometry, durable polymethylpentene membranes, improved surface coatings, integrated heat exchange, and compatibility with digital monitoring systems. Because membrane oxygenators are used in high-risk settings, usability engineering, alarm integration, and clear setup workflows should be central to design strategy.

Manufacturers and suppliers should strengthen supply chain resilience by diversifying critical materials, improving inventory visibility, and supporting hospitals with reliable availability of oxygenators, tubing sets, cannulation accessories, and compatible disposables. Clinical education is equally important; investments in perfusionist training, ECMO simulation, circuit troubleshooting modules, and multidisciplinary protocols can accelerate safe adoption. Regional strategies should account for differences in reimbursement, regulatory pathways, hospital infrastructure, and workforce readiness.

Leaders should also prepare for digital transformation by developing interoperable device ecosystems that support secure data capture, predictive maintenance, and AI-assisted decision support without compromising clinical accountability. Evidence generation should include real-world performance data, post-market surveillance, pediatric and adult use-case documentation, and outcomes-oriented studies. Partnerships with hospitals, academic centers, and training organizations can improve trust, strengthen protocol alignment, and support responsible expansion of extracorporeal life support.

Research Methodology

This executive summary is developed using a structured secondary research methodology focused on verified clinical, regulatory, and industry-relevant sources. The approach emphasizes evidence from peer-reviewed medical literature, clinical practice guidelines, regulatory documentation, standards for medical device safety and quality, hospital technology adoption patterns, and publicly available healthcare infrastructure information. Key themes were assessed across device technology, clinical applications, regional adoption drivers, critical care capacity, perfusion practice, and digital transformation.

The research process includes topic scoping, keyword mapping, source validation, cross-referencing of clinical and technical claims, and exclusion of unsupported market sizing or speculative forecasting. Search themes include membrane oxygenators, extracorporeal membrane oxygenation, cardiopulmonary bypass, hollow-fiber membrane, polymethylpentene oxygenator, perfusion technology, ECMO circuit monitoring, hemocompatibility, pediatric oxygenator, and artificial intelligence in critical care. Insights were synthesized to provide decision-useful analysis for executives, product leaders, procurement teams, and healthcare stakeholders while maintaining neutrality and avoiding unsupported commercial claims.

Conclusion

Membrane oxygenators remain essential to modern cardiac surgery and extracorporeal life support, with their importance increasing as hospitals expand advanced respiratory and circulatory support capabilities. The landscape is being shaped by improvements in hollow-fiber membrane materials, biocompatible coatings, circuit integration, clinical training, supply resilience, and evidence-based ECMO protocols. Regional dynamics vary widely, but the common priorities are safety, reliability, clinician readiness, and access to high-quality extracorporeal support.

Artificial intelligence and digital monitoring are expected to enhance vigilance, quality control, and clinical decision support, provided they are implemented through validated, transparent, and clinician-governed frameworks. Industry leaders that combine engineering excellence, regulatory discipline, robust clinical education, and resilient supply strategies will be best positioned to support the next phase of membrane oxygenator adoption across operating rooms, intensive care units, emergency departments, and transport-based critical care environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Membrane Oxygenators Market, by Type

  • 7.1. Introduction
  • 7.2. Hollow Fiber Membrane Oxygenators
  • 7.3. Flat Sheet Membrane Oxygenators
  • 7.4. Spiral Wound Membrane Oxygenators

8. Membrane Oxygenators Market, by Material

  • 8.1. Introduction
  • 8.2. Polymethylpentene
  • 8.3. Polypropylene
  • 8.4. Polysulfone
  • 8.5. Composite Polymers

9. Membrane Oxygenators Market, by Usage

  • 9.1. Introduction
  • 9.2. Disposable Oxygenators
  • 9.3. Reusable Oxygenators

10. Membrane Oxygenators Market, by Technology

  • 10.1. Introduction
  • 10.2. Microporous Membrane Technology
  • 10.3. Solid Silicone Membrane Technology
  • 10.4. Polypropylene Membrane Technology
  • 10.5. Polymethylpentene Membrane Technology

11. Membrane Oxygenators Market, by Patient Age Group

  • 11.1. Introduction
  • 11.2. Neonatal
  • 11.3. Pediatric
  • 11.4. Adult

12. Membrane Oxygenators Market, by Flow Type

  • 12.1. Introduction
  • 12.2. Continuous
  • 12.3. Pulsatile

13. Membrane Oxygenators Market, by Application

  • 13.1. Introduction
  • 13.2. Blood Oxygenation For Research
    • 13.2.1. Animal Studies
    • 13.2.2. In Vitro Studies
  • 13.3. Cardiopulmonary Bypass
    • 13.3.1. Coronary Artery Bypass Grafting
    • 13.3.2. Valve Replacement Surgery
  • 13.4. Extracorporeal Membrane Oxygenation
    • 13.4.1. Venoarterial ECMO
    • 13.4.2. Venovenous ECMO

14. Membrane Oxygenators Market, by End User

  • 14.1. Introduction
  • 14.2. Ambulatory Surgical Centers
  • 14.3. Hospitals & Research Institutes
  • 14.4. Specialty Cardiac Centers
  • 14.5. Emergency Care Centers

15. Membrane Oxygenators Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. Europe
  • 15.3. North America
  • 15.4. Latin America
  • 15.5. Africa
  • 15.6. Middle East

16. Membrane Oxygenators Market, by Group

  • 16.1. NATO
  • 16.2. G7
  • 16.3. BRICS
  • 16.4. European Union
  • 16.5. ASEAN
  • 16.6. GCC

17. Membrane Oxygenators Market, by Country

  • 17.1. China
  • 17.2. United States
  • 17.3. Japan
  • 17.4. India
  • 17.5. Germany
  • 17.6. United Kingdom
  • 17.7. Australia
  • 17.8. France
  • 17.9. South Korea
  • 17.10. Italy
  • 17.11. Canada
  • 17.12. Russia
  • 17.13. Brazil
  • 17.14. Mexico
  • 17.15. Spain

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2025
  • 18.2. FPNV Positioning Matrix, 2025
  • 18.3. Market Concentration Analysis, 2025
    • 18.3.1. Concentration Ratio (CR)
    • 18.3.2. Herfindahl Hirschman Index (HHI)
  • 18.4. Recent Developments & Impact Analysis, 2025
  • 18.5. Product Portfolio Analysis, 2025
  • 18.6. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Abbott Laboratories
  • 19.2. Andocor N.V.
  • 19.3. B. Braun Melsungen AG
  • 19.4. Braile Biomedica
  • 19.5. Chalice Medical Ltd.
  • 19.6. Cytosorbents Corporation
  • 19.7. Dongguan Kewei Medical Instrument Co., Ltd.
  • 19.8. Eurosets S.r.l.
  • 19.9. Fresenius SE & Co. KGaA
  • 19.10. Getinge AB
  • 19.11. Hemovent GmbH
  • 19.12. Jafron Biomedical
  • 19.13. LivaNova PLC
  • 19.14. Medos Medizintechnik AG
  • 19.15. Medtronic plc
  • 19.16. MicroPort Scientific Corporation
  • 19.17. Nipro Corporation
  • 19.18. Senko Medical Instrument Mfg. Co., Ltd.
  • 19.19. Spectrum Medical Ltd.
  • 19.20. Terumo Corporation
  • 19.21. Xenios AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE OXYGENATORS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MEMBRANE OXYGENATORS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MEMBRANE OXYGENATORS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MEMBRANE OXYGENATORS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MEMBRANE OXYGENATORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 29. GLOBAL MEMBRANE OXYGENATORS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOLLOW FIBER MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOLLOW FIBER MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOLLOW FIBER MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLAT SHEET MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLAT SHEET MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLAT SHEET MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPIRAL WOUND MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPIRAL WOUND MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPIRAL WOUND MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYMETHYLPENTENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYMETHYLPENTENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYMETHYLPENTENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYPROPYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYPROPYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYPROPYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYSULFONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYSULFONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYSULFONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPOSITE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPOSITE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPOSITE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REUSABLE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REUSABLE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REUSABLE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROPOROUS MEMBRANE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROPOROUS MEMBRANE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MICROPOROUS MEMBRANE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SOLID SILICONE MEMBRANE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SOLID SILICONE MEMBRANE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SOLID SILICONE MEMBRANE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYPROPYLENE MEMBRANE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYPROPYLENE MEMBRANE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYPROPYLENE MEMBRANE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYMETHYLPENTENE MEMBRANE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYMETHYLPENTENE MEMBRANE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYMETHYLPENTENE MEMBRANE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTINUOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONTINUOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTINUOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PULSATILE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PULSATILE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PULSATILE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD OXYGENATION FOR RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD OXYGENATION FOR RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD OXYGENATION FOR RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN VITRO STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN VITRO STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IN VITRO STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIOPULMONARY BYPASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIOPULMONARY BYPASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOPULMONARY BYPASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VALVE REPLACEMENT SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VALVE REPLACEMENT SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VALVE REPLACEMENT SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VENOARTERIAL ECMO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VENOARTERIAL ECMO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VENOARTERIAL ECMO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VENOVENOUS ECMO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VENOVENOUS ECMO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VENOVENOUS ECMO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL EMERGENCY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL EMERGENCY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EMERGENCY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 187. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 199. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 200. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 201. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 247. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 249. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 278. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 279. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 284. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 285. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 286. JAPAN MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 296. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 297. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 298. INDIA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 326. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 328. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 345. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 346. FRANCE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 347. SOUTH KOREA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 348. SOUTH KOREA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. SOUTH KOREA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 350. SOUTH KOREA MEMBRANE OXYGENATORS MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)

TABLE